Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Toth

Showing results (31-40 of 524) with videos related to

Pageof 53
Sort By:
Postgraduate Medicine|June 18, 2011
Linagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitusPeter P Toth
Journal of Clinical Hypertension (Greenwich, Conn.)|January 11, 2011
Pleiotropic effects of angiotensin receptor blockers: addressing comorbidities by optimizing hypertension therapyPeter P Toth
Current Diabetes Reviews|March 21, 2012
Effective management of the type 2 diabetes patient with cardiovascular and renal disease: secondary prevention strategies after a myocardial infarctionPeter P Toth
Current Atherosclerosis Reports|August 18, 2005
New insights in the treatment of dyslipidemia: a focus on cardiovascular event reduction and the anti-atherosclerotic effects of atorvastatinPeter P Toth
Drugs|July 10, 2010
Drug treatment of hyperlipidaemia: a guide to the rational use of lipid-lowering drugsPeter P Toth
The Journal of Family Practice|January 5, 2018
Management of Acute Coronary Syndromes in Patients with DiabetesPeter P Toth
Archives of Medical Science : AMS|February 12, 2026
2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk?Peter P Toth, Maciej Banach,
Southern Medical Journal|October 17, 2009
Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathyJan Basile, Peter P Toth
Postgraduate Medicine|December 7, 2020
Heart failure with preserved ejection fraction: strategies for disease management and emerging therapeutic approachesPeter P Toth, Diane Gauthier
Current Atherosclerosis Reports|August 12, 2006
The CARDS trial: diabetic patients dealt a winning handAnnemarie Armani, Peter P Toth
Pageof 53

Showing results (31-40 of 524) with videos related to

Sort By:
Pageof 53
Postgraduate Medicine|June 18, 2011
Linagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitusPeter P Toth
Journal of Clinical Hypertension (Greenwich, Conn.)|January 11, 2011
Pleiotropic effects of angiotensin receptor blockers: addressing comorbidities by optimizing hypertension therapyPeter P Toth
Current Diabetes Reviews|March 21, 2012
Effective management of the type 2 diabetes patient with cardiovascular and renal disease: secondary prevention strategies after a myocardial infarctionPeter P Toth
Current Atherosclerosis Reports|August 18, 2005
New insights in the treatment of dyslipidemia: a focus on cardiovascular event reduction and the anti-atherosclerotic effects of atorvastatinPeter P Toth
Drugs|July 10, 2010
Drug treatment of hyperlipidaemia: a guide to the rational use of lipid-lowering drugsPeter P Toth
The Journal of Family Practice|January 5, 2018
Management of Acute Coronary Syndromes in Patients with DiabetesPeter P Toth
Archives of Medical Science : AMS|February 12, 2026
2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk?Peter P Toth, Maciej Banach,
Southern Medical Journal|October 17, 2009
Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathyJan Basile, Peter P Toth
Postgraduate Medicine|December 7, 2020
Heart failure with preserved ejection fraction: strategies for disease management and emerging therapeutic approachesPeter P Toth, Diane Gauthier
Current Atherosclerosis Reports|August 12, 2006
The CARDS trial: diabetic patients dealt a winning handAnnemarie Armani, Peter P Toth
Pageof 53